Comparisons of changes from baseline between active-device and control patients showed that active-device patients had significantly greater improvement in weekly ( p = 0.009 ) and daily ( p = 0.04 ) leakage episodes , pad testing ( p = 0.005 ) , and vaginal muscle strength ( p = 0.02 ) when compared with control subjects .
